Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.

@article{Kasperkiewicz2011RituximabFT,
  title={Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.},
  author={Michael Kasperkiewicz and Iakov Shimanovich and Ralf J Ludwig and Christian Rose and Detlef Zillikens and Enno Schmidt},
  journal={Journal of the American Academy of Dermatology},
  year={2011},
  volume={65 3},
  pages={
          552-558
        }
}
BACKGROUND Rituximab has been increasingly used in autoimmune blistering dermatoses, mainly in pemphigus. However, only a few larger case series are available on this subject and information on the efficacy of retreatment with rituximab during relapses is lacking. OBJECTIVE We sought to determine efficacy and adverse effects of adjuvant rituximab. METHODS Seventeen patients with refractory autoimmune blistering dermatoses (pemphigus vulgaris [PV], n = 8; pemphigus foliaceus [PF], n = 2… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 54 CITATIONS, ESTIMATED 36% COVERAGE

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES